| Date | Time | Source | Headline | Symbol | Company |
| 02/05/2024 | 6:41AM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:RAIN | Rain Oncology Inc |
| 01/31/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:58PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:56PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:55PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:50PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:44PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:38PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:36PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:34PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 4:32PM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 9:26AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 9:19AM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:RAIN | Rain Oncology Inc |
| 01/26/2024 | 9:13AM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:RAIN | Rain Oncology Inc |
| 01/22/2024 | 4:15PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:RAIN | Rain Oncology Inc |
| 01/19/2024 | 8:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RAIN | Rain Oncology Inc |
| 01/16/2024 | 5:22PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:RAIN | Rain Oncology Inc |
| 01/16/2024 | 5:18PM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:RAIN | Rain Oncology Inc |
| 01/03/2024 | 2:57PM | PR Newswire (US) | Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm | NASDAQ:RAIN | Rain Oncology Inc |
| 12/28/2023 | 8:48PM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:RAIN | Rain Oncology Inc |
| 12/27/2023 | 9:27AM | Edgar (US Regulatory) | Form SC 14D9 - Solicitation, recommendation statements | NASDAQ:RAIN | Rain Oncology Inc |
| 12/27/2023 | 9:20AM | Edgar (US Regulatory) | Form SC TO-T - Tender offer statement by Third Party | NASDAQ:RAIN | Rain Oncology Inc |
| 12/14/2023 | 6:06AM | Edgar (US Regulatory) | Form SC 14D9 - Solicitation, recommendation statements | NASDAQ:RAIN | Rain Oncology Inc |
| 12/14/2023 | 6:06AM | Edgar (US Regulatory) | Form SC TO-C - Written communication relating to an issuer or third party | NASDAQ:RAIN | Rain Oncology Inc |
| 12/14/2023 | 6:04AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RAIN | Rain Oncology Inc |
| 11/09/2023 | 4:05PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:RAIN | Rain Oncology Inc |
| 11/09/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RAIN | Rain Oncology Inc |
| 09/12/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN) | NASDAQ:RAIN | Rain Oncology Inc |
| 09/06/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN) | NASDAQ:RAIN | Rain Oncology Inc |
| 08/29/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN) | NASDAQ:RAIN | Rain Oncology Inc |